Lee TSDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea; Center for Nanomedicine, Institute for Basic Science (IBS), Yonsei University, Seoul 30722, Korea; Yonsei-IBS Institute, Yonsei University, Seoul 30722, Korea;
Lee JYDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea;
Kyung JWDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Korea;
Yang YBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea;
Park SJDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea;
Lee SDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea;
Pavlovic IDepartment of Chemistry, University of Zurich, 8057 Zurich, Switzerland;
Kong BDepartment of Genetic Engineering and Center for Human Interface Nanotechnology, Sungkyunkwan University, Suwon 16419, Korea;
Jho YSAsia-Pacific Center for Theoretical Physics, Pohang, Gyeongbuk 37673, Korea;
Jessen HJInstitute of Organic Chemistry, Albert-Ludwigs-University Freiburg, Freiburg 79104, Germany;
Kweon DHDepartment of Genetic Engineering and Center for Human Interface Nanotechnology, Sungkyunkwan University, Suwon 16419, Korea;
Shin YKDepartment of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, IA 50011;
Kim SHDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Korea; Department of Physiology, School of Medicine, Neurodegeneration Control Research Center, Kyung Hee University, Seoul 02447, Korea; sunghyunkim@khu.ac.kr tyyoon@yonsei.ac.kr seyunkim@kaist.ac.kr.
Yoon TYCenter for Nanomedicine, Institute for Basic Science (IBS), Yonsei University, Seoul 30722, Korea; Yonsei-IBS Institute, Yonsei University, Seoul 30722, Korea; sunghyunkim@khu.ac.kr tyyoon@yonsei.ac.kr seyunkim@kaist.ac.kr.
Kim SDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea; Korea Advanced Institute of Science and Technology Institute for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea sunghyunkim@khu.ac.kr tyyoon@yonsei.ac.kr seyunkim@kaist.ac.kr.
English
Inositol pyrophosphates such as 5-diphosphoinositol pentakisphosphate (5-IP7) are highly energetic inositol metabolites containing phosphoanhydride bonds. Although inositol pyrophosphates are known to regulate various biological events, including growth, survival, and metabolism, the molecular sites of 5-IP7 action in vesicle trafficking have remained largely elusive. We report here that elevated 5-IP7 levels, caused by overexpression of inositol hexakisphosphate (IP6) kinase 1 (IP6K1), suppressed depolarization-induced neurotransmitter release from PC12 cells. Conversely, IP6K1 depletion decreased intracellular 5-IP7 concentrations, leading to increased neurotransmitter release. Consistently, knockdown of IP6K1 in cultured hippocampal neurons augmented action potential-driven synaptic vesicle exocytosis at synapses. Using a FRET-based in vitro vesicle fusion assay, we found that 5-IP7, but not 1-IP7, exhibited significantly higher inhibitory activity toward synaptic vesicle exocytosis than IP6 Synaptotagmin 1 (Syt1), a Ca(2+) sensor essential for synaptic membrane fusion, was identified as a molecular target of 5-IP7 Notably, 5-IP7 showed a 45-fold higher binding affinity for Syt1 compared with IP6 In addition, 5-IP7-dependent inhibition of synaptic vesicle fusion was abolished by increasing Ca(2+) levels. Thus, 5-IP7 appears to act through Syt1 binding to interfere with the fusogenic activity of Ca(2+) These findings reveal a role of 5-IP7 as a potent inhibitor of Syt1 in controlling the synaptic exocytotic pathway and expand our understanding of the signaling mechanisms of inositol pyrophosphates.